ExSight Ventures is a life sciences venture capital firm specializing in early-stage investments in innovative ophthalmic diagnostic and treatment solutions. Founded to address the scarcity of early-stage funding in the life sciences sector, the firm leverages the expertise of its team, which includes two accomplished retinal surgeons, to identify and support breakthrough technologies in ophthalmology. ExSight Ventures focuses on biotechnology, medical devices, pharmaceuticals, and software solutions with ophthalmic applications, aiming to improve the diagnosis and treatment of vision diseases.